Uzunparmak B - Search Results

1

Pancreatic cancer microenvironment: a current dilemma.

Uzunparmak B, Sahin IH. Uzunparmak B, et al. Clin Transl Med. 2019 Jan 15;8(1):2. doi: 10.1186/s40169-019-0221-1. Clin Transl Med. 2019. PMID: 30645701 Free PMC article. Review.

2

Comment on: α-smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study.

Sahin IH, Uzunparmak B. Sahin IH, et al. Among authors: uzunparmak b. Br J Cancer. 2015 May 26;112(11):1838. doi: 10.1038/bjc.2014.663. Epub 2015 Jan 20. Br J Cancer. 2015. PMID: 25602961 Free PMC article. No abstract available.

3

Comment on "ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer".

Uzunparmak B, Sahin IH. Uzunparmak B, et al. Br J Cancer. 2018 Oct;119(7):908. doi: 10.1038/s41416-018-0279-3. Epub 2018 Oct 9. Br J Cancer. 2018. PMID: 30297772 Free PMC article. No abstract available.

4

Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis.

Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton J, Sikora AG, Myers JN, Pickering CR. Uzunparmak B, et al. JCI Insight. 2020 Dec 3;5(23):e139837. doi: 10.1172/jci.insight.139837. JCI Insight. 2020. PMID: 33108350 Free PMC article.

5

Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

DiPeri TP, Evans KW, Wang B, Zhao M, Akcakanat A, Raso MG, Rizvi YQ, Zheng X, Korkut A, Varadarajan K, Uzunparmak B, Dumbrava EE, Pant S, Ajani JA, Pohlmann PR, Jensen VB, Javle M, Rodon J, Meric-Bernstam F. DiPeri TP, et al. Among authors: uzunparmak b. Cancer Discov. 2024 May 1;14(5):828-845. doi: 10.1158/2159-8290.CD-23-0838. Cancer Discov. 2024. PMID: 38358339 Free PMC article. Clinical Trial.

6

Limited Independent Follow-Up with Germline Testing of Variants Detected in BRCA1 and BRCA2 by Tumor-Only Sequencing.

Nowlen CJ, Daniels M, Uzunparmak B, Ileana Dumbrava EE, Yuan Y, Patel KP, Rayes N, Harkenrider J, Wathoo C, Veazie J, Luna KA, Wang W, Horombe C, Javle M, Ahnert JR, Yap TA, Arun B, Lu KH, Meric-Bernstam F. Nowlen CJ, et al. Among authors: uzunparmak b. J Immunother Precis Oncol. 2024 Feb 5;7(1):7-17. doi: 10.36401/JIPO-23-2. eCollection 2024 Feb. J Immunother Precis Oncol. 2024. PMID: 38327755 Free PMC article.

7

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.

van der Vliet HJ, Koon HB, Yue SC, Uzunparmak B, Seery V, Gavin MA, Rudensky AY, Atkins MB, Balk SP, Exley MA. van der Vliet HJ, et al. Among authors: uzunparmak b. Clin Cancer Res. 2007 Apr 1;13(7):2100-8. doi: 10.1158/1078-0432.CCR-06-1662. Clin Cancer Res. 2007. PMID: 17404092 Clinical Trial.

8

HER2-low expression in patients with advanced or metastatic solid tumors.

Uzunparmak B, Haymaker C, Raso G, Masciari S, Wang L, Lin H, Gorur A, Kirby B, Cimo AM, Kennon A, Ding Q, Urschel G, Yuan Y, Feng G, Rizvi Y, Hussain A, Zhu C, Kim P, Abbadessa G, Subbiah V, Yap TA, Rodon J, Piha-Paul SA, Meric-Bernstam F, Dumbrava EE. Uzunparmak B, et al. Ann Oncol. 2023 Nov;34(11):1035-1046. doi: 10.1016/j.annonc.2023.08.005. Epub 2023 Aug 22. Ann Oncol. 2023. PMID: 37619847

9

Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formation.

Buelow B, Uzunparmak B, Paddock M, Scharenberg AM. Buelow B, et al. Among authors: uzunparmak b. PLoS One. 2009 Jul 29;4(7):e6339. doi: 10.1371/journal.pone.0006339. PLoS One. 2009. PMID: 19641624 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page